A Phase II, Multicenter, Single-Arm Study to Evaluate the Safety and Efficacy of Deferasirox after Hematopoietic Stem Cell Transplantation in Children with β-Thalassemia Major.
![](/xmlui/themes/Mirage2//images/mime2.png)
View/ Open
Date
2018Author
Yesılıpek, M akif
Karasu, Gulsun
Kaya, Zuhre
Kuskonmaz, B Baris
Uygun, Vedat
Dag, I
Ozudugru, O
Ertem, Mehmet